Risk-Based Approaches to Clinical Investigations

RELATED
- Snapshot Shows Targeted Site Monitoring Trend
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring

This Compendium consists of presentation materials submitted by speakers that complement their presentations from CBI’s Risk-Based Approaches to Clinical Investigations. CBI has provided information and networking opportunities for thousands of executives in industries such as pharmaceuticals, biotech, medical devices and managed care. We understand what an important resource this material is and we have made a concerted effort to secure biographical sketches, outlines and related materials from the conference.

View agenda from this past conference

PRESENTATIONS:

- Dean Gittleman MS, Senior Director, Operations, Target Health Inc.Read Bio

- Imogene Grimes Ph.D., Senior Director, Biostatistics, Otsuka Pharmaceutical Development & Commercialization, Inc. Read Bio

- Darlene Kalinowski, Associate Director, eDC Operations, Bristol-Myers SquibbRead Bio

- Jules T. Mitchel MBA, Ph.D., President, Target Health Inc.Read Bio

- Anne Marie Murphy, Principal, Hyman, Phelps & McNamaraRead Bio

- Mary Oster, Board Chair, New England Institutional Review BoardRead Bio

- Sharon S. Reinhard M.S., Associate Director, Compliance Operations & Oversight, Endo PharmaceuticalsRead Bio

- Vadim Tantsyura MS, MA, DrPh (c) Clinical Trial Operations Manager, Sanofi
- Vadim Tantsyura OpeningRead Bio

- Kerri Weingard NP, Research Director, Accumed Research AssociatesRead Bio

- Christian Yavorsky Ph.D. Chief Science Officer & Clinical Director, CROnos Clinical Consulting ServicesRead Bio

- Stephen Young, Senior Product Director, Medidata SolutionsRead Bio